Apidra 100IU Cartridge 1X3ml

Diabetes Rx required

Best Price*  ₹ 553.94
MRP ₹692.43
(Inclusive of all taxes) * Mkt: Sanofi India Limited * Country of Origin: Germany * Delivery charges if applicable will be applied at checkout

Check Availability & Expiry

Cold Storage Product cannot be returned or exchanged. Available at selected pin codes.



APIDRA 100IU contains Insulin glulisine which belongs to the group of medicines called rapid-acting recombinant human insulin analog. It is used to lower high blood sugar levels in patients with diabetes mellitus. Diabetes mellitus is a chronic disease associated with abnormally high levels of glucose in the blood due to inadequate production of insulin (a hormone produced by pancreas to metabolize glucose) or inadequate sensitivity of cells to insulin.

Always consult your doctor before doing any physical activity and be careful about the time intervals between your meals. Regularly monitor your blood sugar levels, because this medicine may cause hypoglycemia which may put your life in danger. To avoid this potential risk, always carry some amount of sugar with you.

APIDRA 100IU should be injected only using a pre-filled pen. It can be taken within 15 minutes of a meal or soon after a meal. It can be used in both in adults as well as in adolescents and children aged 6 years or above. Avoid smoking and consumption of alcohol while taking this medicine. The most common side effect of this medicine is application site redness, itching or swelling. Before taking this medicine inform your doctor if you have any kidney, liver or heart disease. Dose adjustments may be required for pregnant and breastfeeding women.


  • Treats diabetes mellitus in adults and in adolescents and children aged 6 years or above


Insulin glulisine acts in same way as naturally produced insulin and helps glucose enter cells from the blood and thus controls the level of blood glucose. Hence it reduces the symptoms and complications of diabetes.


APIDRA 100IU should be taken within 15 minutes before or soon after meals. This medicine can be injected under the skin (subcutaneously) of the abdominal wall, thigh or upper arm or as an intravenous infusion in the abdominal wall by a healthcare professional.

Always examine the vial closely before use for any visible particles in it. Do not mix or shake the vial before use. If insulin glulisine is needed to be mixed with NPH human insulin, draw insulin glulisine first in the syringe and then mix with NPH. It should be administered immediately after mixing. Do not mix insulin glulisine (vial) with any other preparations other than NPH.

Do not overuse any injection site and be sure to use a different injection site each time to avoid application site reactions. Your doctor will decide the correct dose, duration and time for you depending upon your age, weight and body condition.



  • Hypoglycemia (symptoms are sweating, clammy skin, anxiety, fast or irregular heartbeat, high blood pressure, headache, nausea, vomiting, tiredness, sleepiness, depression, confusion, speech disturbances, visual disorders, paralysis, numbness and tingling sensations in area of mouth, convulsions and loss of consciousness)
  • Hyperglycemia (Symptoms are feeling thirst, increased need to urinate, feeling tired, dry skin, flushing of face, loss of appetite, low blood pressure or fast heartbeat and glucose)
  • Systemic allergic reactions (such as skin rash and itching all over the body, swelling of skin or mucous membranes, shortness of breath, low blood pressure and fast heartbeat with sweating)


  • application site reactions (such as injection site redness, pain, itching, swelling or inflammation)


Nausea or vomiting:

Try taking this medicine with, or just after meals. Stick to simple meals. Do not eat rich or spicy food.


Rest and drink plenty of fluids. Do not drink too much alcohol. Ask your doctor to recommend a painkiller.



APIDRA 100IU should be used with caution in pregnant women, because the dose of the insulin should be monitored and suitably altered during pregnancy and after giving birth to avoid hypoglycemia. Consult your doctor for advice.


The dose and intake of APIDRA 100IU should be altered suitably in the case of breastfeeding women. Consult your doctor for advice before taking.


Do not drive or operate any machines if your ability is affected by this medicine.


Avoid consumption of alcohol while taking this medicine.


APIDRA 100IU should be taken with caution in patients with severe kidney disease. Consult your doctor for advice.


APIDRA 100IU should be taken with caution in patients with severe liver disease. Consult your doctor for advice.


Do not take this medicine if you are allergic (hypersensitive) to insulin glulisine or any other ingredients in this medicine.


APIDRA 100IU should be taken with caution in patients with severe heart disease or stroke. Consult your doctor for advice.


Talk to your doctor, if you are taking,

  • other medicines used to treat diabetes orally (e.g. metformin, acarbose, pioglitazone, empagliflozin, sitagliptin or saxagliptin)
  • medicines used to reduce high blood pressure like beta-blockers (e.g. metoprolol, atenolol, propranolol), ACE inhibitors (e.g. captopril, enalapril), alpha-agonist sympatholytics (e.g. clonidine) or diuretics (e.g. furosemide)
  • medicines used to treat depression (e.g. sertraline, fluoxetine, citalopram, escitalopram, or selegiline)
  • medicines used to treat psychiatric disorders such as phenothiazine derivatives (e.g. chlorpromazine, mesoridazine), atypical antipsychotics (e.g. olanzapine and clozapine) or lithium
  • medicines used to treat HIV such as protease inhibitors (e.g.  atazanavir, ritonavir, saquinavir) 
  • medicines used to treat pain (e.g. pentoxifylline, propoxyphene, acetylsalicylic acid)
  • contraceptive pill (birth control pills)
  • steroids (used to treat inflammation) e.g. dexamethasone
  • thyroid hormone replacement therapy (used to treat thyroid disorders)
  • sulphonamide antibiotics (used to treat bacterial infection) e.g. sulphasalazine, sulfamethoxazole
  • salbutamol or terbutaline (used to treat asthma)
  • danazol (used to treat endometriosis)
  • disopyramide (used to treat certain heart diseases)
  • glucagon (a pancreatic hormone used to treat severe hypoglycemia)
  • isoniazid (a medicine used to treat tuberculosis)
  • somatropin (a growth hormone)
  • Pentamidine (used to treat parasite infections)


Drug :   Insulin glulisine
Pharmacological Category :   Rapid-acting recombinant human insulin analog, Anti-diabetic
Therapeutic Indication :   Diabetes mellitus
Dosage Forms :   Pen, Catridge


  • Keep out of reach of children
  • For not in-use pens: store in a refrigerator (2-8°C). Do not freeze
  • For in-use pens: store below 25°C (for a maximum of 4 weeks) and away from direct heat or light


What is the onset of action for APIDRA 100IU?

This medicine has a rapid onset of action (within 10-20 minutes) and so, it can be taken within 15 minutes before or after a meal.

What are the side effects of APIDRA 100IU?

This medicine is generally well tolerated and does not cause any side effects. However, it may cause application site reactions like redness, itching or swelling in some individuals. Contact your doctor if this bothers you.

Why we should not repeatedly inject APIDRA 100IU at the same site?

This medicine is not advised to inject at same site, because it may create a lumpy area under your skin. Always try to inject the medicine by rotating to its adjacent areas apart from previous sites to prevent skin changes such as lumps under the skin.

Can APIDRA 100IU be mixed with other insulins?

This medicine can be mixed only with NPH human insulin at suitable proportions. Consult your doctor before taking.


1. Alvin C. Powers and David D’Alessio. Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page - 1251

2. KD. Tripathi. Insulin, oral hypoglycemic drugs and glucagon. Essentials of medical pharmacology. Seventh edition. 2013. Page - 265

3. Sanofi. ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on December 2009] [Accessed 16th November 2020] https://clinicaltrials.gov/ct2/show/NCT00272064

4. Sanofi. Study of Safety and Effectiveness of Apidra® in Combination with Basal Insulin in Patients with Type 1 & 2 Diabetes Mellitus (SCALE). NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on September 2010] [Accessed 16th November 2020] https://clinicaltrials.gov/ct2/show/NCT00526513

5. Satoru Yamada. Insulin glulisine in the management of diabetes. NCBI; PMC U.S. National Library of Medicine, National Institute of Health. July 2009. [Accessed 16th November 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048006/

6. Sanofi-Aventis Deutschland GmbH. Electronic Medicines Compendium (EMC); [Revised on July 2020] [Accessed 16th November 2020] https://www.medicines.org.uk/emc/files/pil.2499.pdf


  • Fasting plasma glucose (FPG) test
  • Random plasma glucose (RPG) test
  • Glucose challenge test
  • Oral glucose tolerance test (OGTT)


    Net Qty
    1 N
    Item Weight
    15 g
    Hsn Code

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Apidra 100IU Cartridge 1X3ml

Apidra 100IU Cartridge 1X3ml Mkt: Sanofi India Limited

M.R.P.: Rs.692.43
Copyright© 2022. All Rights Reserved.